Profil Financier
Lou Jing & family occupe actuellement le rang #3029 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $1.3 B (-$16 M sur 24h).
Lou Jin is chairman and CEO of 3SBIO Inc, a biopharmaceutical company.
The company first went public on the Nasdaq in 2007 before privatizing in 2013. It listed again in Hong Kong in 2015.
The company's main research and development centers are in Shenyang, Shanghai, Shenzhen and Hangzhou.